No abstract available
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Anti-Inflammatory Agents, Non-Steroidal / toxicity
-
Bone Neoplasms / enzymology
-
Bone Neoplasms / pathology
-
Cyclooxygenase 1
-
Cyclooxygenase 2
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors / pharmacology
-
Cyclooxygenase Inhibitors / therapeutic use*
-
Cyclooxygenase Inhibitors / toxicity
-
Dinoprostone / biosynthesis
-
Drug Evaluation, Preclinical
-
Humans
-
Indans / pharmacology
-
Indans / toxicity
-
Indomethacin / pharmacology
-
Indomethacin / toxicity
-
Inflammation / drug therapy*
-
Inflammation / metabolism
-
Isoenzymes / antagonists & inhibitors*
-
Isoenzymes / blood
-
Isoenzymes / drug effects*
-
Isoenzymes / physiology
-
Membrane Proteins
-
Neoplasm Proteins / antagonists & inhibitors
-
Osteosarcoma / enzymology
-
Osteosarcoma / pathology
-
Prostaglandin-Endoperoxide Synthases / blood
-
Prostaglandin-Endoperoxide Synthases / drug effects*
-
Prostaglandin-Endoperoxide Synthases / physiology
-
Rats
-
Saimiri
-
Stomach Ulcer / chemically induced
-
Substrate Specificity
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors
-
Indans
-
Isoenzymes
-
L 745337
-
Membrane Proteins
-
Neoplasm Proteins
-
Cyclooxygenase 1
-
Cyclooxygenase 2
-
PTGS1 protein, human
-
PTGS2 protein, human
-
Prostaglandin-Endoperoxide Synthases
-
Ptgs1 protein, rat
-
Dinoprostone
-
Indomethacin